CAR T-Cell Production Using Nonviral Approaches
Chimeric antigen receptor T-cells (CAR T-cells) represent a novel and promising approach in cancer immunotherapy. According to the World Health Organization (WHO), the number of oncological patients is steadily growing in developed countries despite immense progress in oncological treatments, and th...
Main Authors: | Viktor Lukjanov, Irena Koutná, Pavel Šimara |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/6644685 |
Similar Items
-
Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium
by: Simon Farkas, et al.
Published: (2020-05-01) -
Umbilical Cord-Derived Mesenchymal Stem Cells are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications
by: Lenka Tesarova, et al.
Published: (2020-07-01) -
Nonviral Methods for Inducing Pluripotency to Cells
by: Ryan O'Doherty, et al.
Published: (2013-01-01) -
The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
by: Lenka Tesarova, et al.
Published: (2016-01-01) -
Nonviral genome engineering of natural killer cells
by: Gabrielle M. Robbins, et al.
Published: (2021-06-01)